PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel
Pfisterer, Katharina, Fusi, Alberto, Klinghammer, Konrad, Knödler, Maren, Nonnenmacher, Anika, Keilholz, Ulrich
Published in Head & neck (01.04.2015)
Published in Head & neck (01.04.2015)
Get full text
Journal Article
Correlation between PI3K/PTEN/AKT/mTOR pathway genetic variations and clinical outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment
Fusi, Alberto, Pfisterer, Katharina, Klinghammer, Konrad Friedrich, Knoedler, Maren, Nonnenmacher, Anika, Keilholz, Ulrich
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article